New treatment option for Depression - Major Depressive Disorder
Official title Group-based ACT for Psychological Distress of Young People
ClinicalTrials.gov ID: NCT07617467
What this study is testing
- What it's testing
- This clinical study investigates the effectiveness of two psychological treatment formats for young people aged 16-25 with symptoms of depression, anxiety, stress, or interpersonal difficulties. The study compares group-based Acceptance and Commitment Therapy (ACT) with treatment as usual (TAU), most frequent that would be individual psychotherapy, both of which are established treatment approaches.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 25
You may be able to join if
- Score on DASS-21 depression scale ≤ 14
You likely can't join if
- Psychosis
The study team makes the final eligibility decision.
Where it's taking place
- Arendal, Agder, Norway
- Kristiansand, Agder, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Arendal, Agder, Norway; Kristiansand, Agder, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.